IP Verse

Anionic Polysaccharides Functionalised By A Hydrophobic Acid Derivative - EP2516473

The patent EP2516473 was granted to Adocia on Sep 30, 2020. The application was originally filed on Dec 23, 2010 under application number EP10814709A. The patent is currently recorded with a legal status of "Revoked".

EP2516473

ADOCIA
Application Number
EP10814709A
Filing Date
Dec 23, 2010
Status
Revoked
May 6, 2022
Publication Date
Sep 30, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HAMMERJun 29, 2021GRUNECKER PATENTADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0792888
DESCRIPTIONUS2387201
DESCRIPTIONUS2954372
DESCRIPTIONUS4826818
INTERNATIONAL-SEARCH-REPORTEP1493754
INTERNATIONAL-SEARCH-REPORTWO2007116143
INTERNATIONAL-SEARCH-REPORTWO2008038111
INTERNATIONAL-SEARCH-REPORTWO2009127940
OPPOSITIONUS2005203054
OPPOSITIONUS2008221062
OPPOSITIONUS2008306022
OPPOSITIONUS6107410

Non-Patent Literature (NPL) Citations (29) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- ABURTO, J ET AL., J. APPL. POLYM. SCI., (1999), vol. 74, pages 1440 - 1451
DESCRIPTION- DALE, D.J. ET AL., ORG. PROCESS. RES. DEV., (2002), vol. 6, pages 767 - 772
DESCRIPTION- HEINZE, T. ET AL., CELLULOSE, (2003), vol. 10, pages 283 - 296
DESCRIPTION- KNôCKLER, H.-J. ET AL., SYNLETT, (1997), pages 925 - 928
DESCRIPTION- L.ALETIN, AJ ET AL., VYSOKOMOL SOEDIN SER A, (1968), vol. 10, page 652
DESCRIPTION- MANUEL ET AL., POLYMER, (1998), vol. 39, no. 13, pages 2751 - 2757
DESCRIPTION- MOOROKA, T. ET AL., J. APPL. POLYM. SCI., (1984), vol. 29, pages 3981 - 3990
DESCRIPTION- NICHIFOR, MARIETA ET AL., EUR. POLYM. J., (1999), vol. 35, pages 2125 - 2129
DESCRIPTION- PAL, A ET AL., TETRAHEDRON, (2007), vol. 63, pages 7334 - 7348
DESCRIPTION- PAUL, R ET AL., J. ORG. CHEM., (1962), vol. 27, pages 2094 - 2099
OPPOSITION- Adamo Fini, Giuseppe Fazio, Gorgio Feroci, "Solubility and solubilization properties of non-steroidal anti-inflammatory drugs", International Journal of Pharmaceutics, (19950101), vol. 126, pages 95 - 102, XP055938116
OPPOSITION- Anonymous, "2-Acetoxybenzoic acid", .ilo.org, (19980301), .ilo.org, URL: https://www.ilo.org/dyn/icsc/showcard .display?p card _id=0822&p ed it=&p version=2&p lang=en, (20220704), XP055938106
OPPOSITION- Anonymous, "Chondroitin sulfate sodium", sigmaaldrich.com, (20210101), sigmaaldrich.com, URL: https://www.sigmaaldrich.com/US/en/substance/chondroitinsulfatesodium 123459082079, (20220704), XP055938154
OPPOSITION- Anonymous , "COMPOUND SUMMARY Chondroitin sulfate", pubchem, XP055938147
OPPOSITION- Anonymous , "flurbiprofen", pubchem, XP055938098
OPPOSITION- Anonymous , " Hyaluronic-acid", PubChem , XP055938086
OPPOSITION- Anonymous, "Hyaluronic acid sodium salt from Streptococcus equi", sigmaaldrich, (20210622), sigmaaldrich, URL: https://www.sigmaaldrich.com/US/en/product/sigma/75048, (20220704), XP055938082
OPPOSITION- Anonymous , "ibuprofen ", pubchem , XP055938092
OPPOSITION- Anonymous , "naproxen", pubchem, XP055938094
OPPOSITION- Anonymous, "Showing Compound trans-cinnamate (FDB031209) ", foodb, (20150507), foodb, URL: https://foodb.ca/compounds/FDB031209, (20220704), XP055938141
OPPOSITION- Bratu Ioan, Hernanz Antonio, "FT-IR SPECTROSCOPY OF INCLUSION COMPLEXES OF β-CYCLODEXTRIN WITH FENBUFEN AND IBUPROFEN", Rom. Journ. Phys., (20050101), vol. 50, no. 9-10, pages 1063 - 1068, XP055938111
OPPOSITION- Savita Vyas*, Piyush Trivedi 2 And Subhash Chandra Chaturvedi, "DEXTRAN-ETODOLAC CONJUGATES: SYNTHESIS, IN VITRO AND IN VIVO EVALUATION", Acta Poloniae Pharmaceutica ñ Drug Research, (20090101), vol. 66, no. 2, pages 201 - 206, XP055938121
OPPOSITION- Uner, M. ; Gonullu, U. ; Yener, G. ; Altinkurt, T., "A new approach for preparing a controlled release ketoprofen tablets by using beeswax", Il Farmaco, Elsevier France * Editions Scientifiques et Medicales, FR, FR , (20050101), vol. 60, no. 1, ISSN 0014-827X, pages 27 - 31, XP027697531
OPPOSITION- Xiangwei Zhu,, Wenjuan Guo, Huizhi Li, Guangyou Zhang, Meishan Pei, Luyan Wang &jijun Feng, "Synthesis of a novel water-soluble conjugated polyelectrolyte based on polycyclopentadithiophene backbone and its application for heparin detection", Designed Monomers and Polymers, (20140101), vol. 17, no. 7, pages 624 - 628, XP055938145
OPPOSITION- TARA POUYANI AND GLENN D. PRESTWICH, "Functionalized Derivatives of Hyaluronic Acid Oligosaccharides: Drug carriers and Novel biomaterials", Bioconjugate Chemistry, American Chemical Society, US, US , (19940101), vol. 5, doi:10.1021/bc00028a010, ISSN 1043-1802, pages 339 - 347, XP002274514
OPPOSITION- Park Kyeongsoon, Kim Kwangmeyung, Kwon Ick Chan, Kim Sang Kyoon, Lee Seulki, Lee Dong Yun, Byun Youngro, "Preparation and Characterization of Self-Assembled Nanoparticles of Heparin-Deoxycholic Acid Conjugates", Langmuir, American Chemical Society, US, US , (20041201), vol. 20, no. 26, doi:10.1021/la048646i, ISSN 0743-7463, pages 11726 - 11731, XP055938070
OPPOSITION- Colvin B T, Barrowcliffe T W, "The British Society for Haematology Guidelines on the use and monitoring of heparin 1992: second revision. BCSH Haemostasis and Thrombosis Task Force.", Journal of Clinical Pathology, BMJ Publishing Group, GB, GB , (19930201), vol. 46, no. 2, doi:10.1136/jcp.46.2.97, ISSN 0021-9746, pages 97 - 103, XP055938089
OPPOSITION- Yang Jie, Zhu Yishen, Diao Yongqin, Yin Caiyun, "Rheological and Mechanical Analyses of Felbinac Cataplasms by Using Box-Behnken Design", Pharmaceutics, vol. 10, no. 3, doi:10.3390/pharmaceutics10030088, page 88, XP055938109
OPPOSITION- Nurhikmah Wilda, "Dissolution Profile of Mefenamic Acid Solid Dosage Forms in Two Compendial and Biorelevant (FaSSIF) Media", Scientia Pharmaceutica, Oesterreichische Apotheker-Verlagsgesellschaft mbH, Austria, Austria , (20160101), vol. 84, no. 1, doi:10.3797/scipharm.ISP.2015.09, ISSN 0036-8709, pages 181 - 190, XP055938113

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents